Description

2H-3,9a-Methano-1-benzoxepin-4,5,6,7,9,10-hexol,5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-, 4,6,7,10-tetraacetate5-benzoate, (3R,4R,5S,5aS,6R,7S,9S,9aS,10R)- is a complex, stereochemically defined organic compound with a high degree of functionalization. This compound is of significant interest as a key intermediate or advanced building block in the synthesis of specialized fine chemicals and active pharmaceutical ingredients (APIs). It is primarily sought by research institutions and pharmaceutical development teams engaged in the creation of novel therapeutic agents, particularly where intricate molecular architecture is required.

Application

• Pharmaceutical Intermediate: Serves as a critical chiral building block in the multi-step synthesis of complex drug candidates, especially in oncology and anti-infective research.
• Organic Synthesis Research: Used in academic and industrial R&D for developing new synthetic methodologies involving polycyclic and polyfunctional molecules.
• Fine Chemical Production: Acts as a precursor for the manufacture of high-value specialty chemicals with specific stereochemical configurations.
• Reference Standard: Employed as an analytical standard in quality control laboratories for method development and impurity profiling in related pharmaceutical processes.

Basic Information

Product Name	2H-3,9a-Methano-1-benzoxepin-4,5,6,7,9,10-hexol,5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-, 4,6,7,10-tetraacetate5-benzoate, (3R,4R,5S,5aS,6R,7S,9S,9aS,10R)-
CAS No.	116159-73-0
Molecular Formula	C34H42O14
Molecular Weight	674.70 g/mol
Synonyms	(3R,4R,5S,5aS,6R,7S,9S,9aS,10R)-5a-(Acetoxymethyl)octahydro-2,2,9-trimethyl-4,6,7,10-tetraacetoxy-5-benzoyloxy-2H-3,9a-methano-1-benzoxepine-4,5,6,7,9,10-hexol; 4,6,7,10-Tetra-O-acetyl-5-O-benzoyl-2,3-dideoxy-1,5-anhydro-3-C-[(R)-1-acetoxyethyl]-4-C-hydroxymethyl-D-erythro-L-galacto-decitol; A derivative of Acarviosin; A complex polyacetylated benzoxepine derivative.
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. Each batch is characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry to confirm identity, purity, and stereochemical integrity. Certificates of Analysis (COA) detailing batch-specific results are available upon request. We adhere to cGMP guidelines for the production of materials intended for pharmaceutical research and development.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as specified on the certificate of analysis. This compound may be hygroscopic; store in a dry environment. Keep container tightly sealed in a well-ventilated place.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Purity (HPLC, Area %)	≥ 97.0%
Specific Rotation	Contact for details
Residual Solvents (GC)	Complies with ICH Q3C
Water Content (KF)	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.